Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,229 | 132 | 94.3% |
| Honoraria | $350.00 | 1 | 5.3% |
| Gift | $30.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,185 | 62 | $0 (2024) |
| Alimera Sciences, Inc. | $1,076 | 9 | $0 (2024) |
| Alcon Vision LLC | $859.63 | 5 | $0 (2024) |
| Genentech USA, Inc. | $380.23 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $373.08 | 10 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $303.75 | 2 | $0 (2022) |
| Apellis Pharmaceuticals, Inc. | $277.71 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $274.35 | 5 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $266.54 | 3 | $0 (2022) |
| Alcon Research Ltd | $265.84 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $994.50 | 29 | GlaxoSmithKline, LLC. ($214.78) |
| 2023 | $1,272 | 51 | GlaxoSmithKline, LLC. ($688.35) |
| 2022 | $1,747 | 35 | GlaxoSmithKline, LLC. ($281.66) |
| 2021 | $814.42 | 7 | Alimera Sciences, Inc. ($549.19) |
| 2020 | $557.06 | 3 | Alimera Sciences, Inc. ($350.00) |
| 2019 | $726.50 | 4 | Alcon Vision LLC ($726.50) |
| 2018 | $466.89 | 4 | Alcon Research Ltd ($265.84) |
| 2017 | $30.00 | 1 | Heidelberg Engineering, Inc. ($30.00) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $120.27 | General |
| Category: EYE CARE | ||||||
| 11/21/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Ophthalmology | ||||||
| 11/18/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Ophthalmology | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/07/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: Ophthalmology | ||||||
| 09/30/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $30.02 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Ophthalmology | ||||||
| 09/09/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/31/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $133.13 | General |
| Category: Ophthalmology | ||||||
| 07/29/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $32.08 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/03/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Ophthalmology | ||||||
| 06/01/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/21/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Ophthalmology | ||||||
| 04/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: RESPIRATORY | ||||||
| 04/15/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: Ophthalmology | ||||||
| 04/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: RESPIRATORY | ||||||
| 04/01/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $31.86 | General |
| Category: Ophthalmology | ||||||
| 03/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: RESPIRATORY | ||||||
| 03/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 03/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: RESPIRATORY | ||||||
| 02/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: RESPIRATORY | ||||||
| 02/21/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: RESPIRATORY | ||||||
| 02/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 749 | 1,642 | $478,638 | $249,771 |
| 2022 | 8 | 814 | 1,506 | $261,148 | $98,258 |
| 2021 | 9 | 284 | 332 | $47,730 | $21,408 |
| 2020 | 1 | 28 | 28 | $7,000 | $1,537 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 27 | 226 | $256,000 | $156,131 | 61.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 185 | 273 | $53,272 | $25,941 | 48.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 67 | 255 | $68,796 | $24,791 | 36.0% |
| 92134 | Imaging of retina | Office | 2023 | 210 | 473 | $38,589 | $15,152 | 39.3% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 47 | 141 | $14,660 | $8,885 | 60.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 63 | 106 | $16,293 | $7,643 | 46.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 63 | 63 | $19,306 | $6,886 | 35.7% |
| 92250 | Photography of the retina | Office | 2023 | 60 | 68 | $5,349 | $1,867 | 34.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 14 | 14 | $3,770 | $1,557 | 41.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 13 | 23 | $2,604 | $918.93 | 35.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 232 | 343 | $86,384 | $32,933 | 38.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 54 | 183 | $59,746 | $17,916 | 30.0% |
| 92134 | Imaging of retina | Office | 2022 | 278 | 529 | $47,547 | $16,957 | 35.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 117 | 216 | $28,175 | $15,081 | 53.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 49 | 150 | $20,060 | $9,859 | 49.1% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 35 | 35 | $15,351 | $4,300 | 28.0% |
| 92250 | Photography of the retina | Office | 2022 | 28 | 28 | $2,984 | $836.43 | 28.0% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 21 | 22 | $901.52 | $375.80 | 41.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 75 | 80 | $17,080 | $8,469 | 49.6% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 73 | 85 | $7,150 | $2,946 | 41.2% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 32 | 37 | $4,385 | $2,817 | 64.2% |
| 67028 | Injection of drug into eye | Office | 2021 | 17 | 26 | $7,120 | $2,792 | 39.2% |
| J7999 | Compounded drug, not otherwise classified | Office | 2021 | 15 | 30 | $3,020 | $2,040 | 67.5% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 23 | 23 | $5,750 | $1,072 | 18.6% |
| 92250 | Photography of the retina | Office | 2021 | 24 | 24 | $2,400 | $799.60 | 33.3% |
About Dr. Jose Diaz, MD
Dr. Jose Diaz, MD is a Retina Specialist healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2015. The National Provider Identifier (NPI) number assigned to this provider is 1265813810.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Diaz, MD has received a total of $6,609 in payments from pharmaceutical and medical device companies, with $994.50 received in 2024. These payments were reported across 134 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($6,229).
As a Medicare-enrolled provider, Diaz has provided services to 1,875 Medicare beneficiaries, totaling 3,508 services with total Medicare billing of $370,974. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location Miami, FL
- Active Since 06/09/2015
- Last Updated 03/31/2025
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1265813810
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,185
- ILUVIEN (Drug) $1,058
- Constellation (Device) $467.58
- EYLEA (Biological) $271.29
- Vabysmo (Drug) $210.51
- EYLEA HD (Biological) $179.44
- DEXYCU (Drug) $175.59
- Syfovre (Drug) $164.55
- OZURDEX (Drug) $157.30
- EVA, combined machine (Device) $147.70
- YUTIQ (Drug) $146.51
- Tecnis 1-piece IOL (Device) $144.66
- ACTHAR (Biological) $142.39
- TECNIS IOL (Device) $121.88
- VABYSMO (Drug) $121.60
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $120.27
- enVista MX60 IOL (Device) $99.78
- Izervay (Drug) $97.29
- EYSUVIS (Drug) $94.47
- Lucentis (Biological) $48.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Retina Specialist Doctors in Miami
Dr. Philip Rosenfeld, Md, MD
Retina Specialist — Payments: $329,265
Dr. Audina Berrocal, Md, MD
Retina Specialist — Payments: $219,835
Nicolas Yannuzzi, Md, MD
Retina Specialist — Payments: $50,587
Rashid Taher, M.d, M.D
Retina Specialist — Payments: $3,412
Zohar Yehoshua, M.d, M.D
Retina Specialist — Payments: $236.68
Scott Shuldiner, Md, MD
Retina Specialist — Payments: $113.00